Ramp, U., & Krammer, P. H. (2000). Deficient activation of CD95 (APO-1/ Fas )-mediated apoptosis: A potential factor of multidrug resistance in human renal cell carcinoma. British journal of cancer, 82(11), . https://doi.org/10.1054/bjoc.2000.1155
Chicago Style (17th ed.) CitationRamp, Uwe, and Peter H. Krammer. "Deficient Activation of CD95 (APO-1/ Fas )-mediated Apoptosis: A Potential Factor of Multidrug Resistance in Human Renal Cell Carcinoma." British Journal of Cancer 82, no. 11 (2000). https://doi.org/10.1054/bjoc.2000.1155.
MLA (9th ed.) CitationRamp, Uwe, and Peter H. Krammer. "Deficient Activation of CD95 (APO-1/ Fas )-mediated Apoptosis: A Potential Factor of Multidrug Resistance in Human Renal Cell Carcinoma." British Journal of Cancer, vol. 82, no. 11, 2000, https://doi.org/10.1054/bjoc.2000.1155.